PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE
PHENTERMINE HYDROCHLORIDE; TOPIRAMATE
Approval overview PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE is listed in Drugs@FDA under application 208175 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient PHENTERMINE HYDROCHLORIDE; TOPIRAMATE Form and strength CAPSULE, EXTENDED RELEASE;ORAL - EQ 15MG BASE;92MG Sponsor DR REDDYS LABS SA Submission history Latest submission status date: 2025-06-12 00:00:00.
Structured Monograph
Clinical summary
Approval overview PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE is listed in Drugs@FDA under application 208175 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient PHENTERMINE HYDROCHLORIDE; TOPIRAMATE Form and strength CAPSULE, EXTENDED RELEASE;ORAL - EQ 15MG BASE;92MG Sponsor DR REDDYS LABS SA Submission history Latest submission status date: 2025-06-12 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.